Credibility:

  • Original Reporting
  • Sources Cited
Original Reporting This article contains new, firsthand information uncovered by its reporter(s). This includes directly interviewing sources and research/analysis of primary source documents.
Sources Cited As a news piece, this article cites verifiable, third-party sources which have all been thoroughly fact-checked and deemed credible by the Newsroom.
Developer Mark Goodman & Associates is building Chicago’s first purpose-built lab and research and development building designed to specifically accommodate the rapidly growing life sciences and biotechnology industry. The building will be located at 400 N Elizabeth St. in Fulton Market. Credit: Mark Goodman & Associates and Solomon Cordwell Buentz

FULTON MARKET — Construction for a 16-story life sciences facility will start this summer in Fulton Market.

The building is scheduled to be completed in 2024, and it will be the first of its kind dedicated Chicago’s life sciences and biotechnology industry, according to a news release. It’ll sit on 1.5 acres of land at 400 N. Elizabeth St. owned by Chicago-based real estate firm Mark Goodman & Associates, Inc.

The building will be designed by the architecture firm Solomon Cordwell Buentz, and it will include 503,000 square feet of laboratory, office and research space, 123 underground parking spaces, a fitness center and a ground-level neighborhood cafe.

The facility will be suited for all sort of life science concentrations, including medical devices, pharmaceuticals, clean energy, biotechnology, food sciences, nanotechnology and more, according to Mark Goodman & Associates.

Construction of 503,000-square-foot lab and office building expected to begin this summer in Fulton Market. The new building at 400 N Elizabeth St will also include pedestrian thruways.

“Because the industry is experiencing record-breaking highs in funding and job growth, the demand for new construction life sciences lab and office space that is customized for the end-user is unparalleled,” principal Mark Goodman said in a statement. “With 400 N. Elizabeth, Chicago will have one of the only new R & D/Lab buildings designed by and for scientists to create best-in-class innovation.”

Numerous factors — including Chicago’s highly educated workforce, medical research institutions and the fact that it’s home to the second-largest urban medical district in the United States — makes the addition of 400 N Elizabeth St. a smart one, according to Mark Goodman & Associates. Executives also said the building being in Fulton Market will attract professionals who want to work in life sciences but also want great neighborhood amenities.

Plans for the building’s immediate area also call for enhanced streetscaping and lighting, plus a pedestrian throughway to connect Elizabeth and Kinzie streets to Ogden Avenue and the center of Fulton Market.

Construction plans include enhancing the streetscape and adding a pedestrian thruway to connect Elizabeth and Kinzie streets to Ogden Avenue and the center of Fulton Market. The thruway will also connect to the proposed Metra station on Ashland Avenue, and it will be a neighborhood gathering place, Goodman said.

There will be seating, planters, spots for food trucks and neighborhood art, Goodman said.

Pre-construction work on the site will begin immediately. Demolition of the current building, the former Lakeshore Beverage distributorship, will start later this year, according to Mark Goodman & Associates.

Groundbreaking for the building will begin in 2023 with construction anticipated to take 20 months.


Support Local News!

Subscribe to Block Club Chicago, an independent, 501(c)(3), journalist-run newsroom. Every dime we make funds reporting from Chicago’s neighborhoods. Already subscribe? Click here to gift a subscription, or you can support Block Club with a tax-deductible donation.

Listen to the Block Club Chicago podcast: